L-Arginine/nitric oxide regulates skeletal muscle development via muscle fibre-specific nitric oxide/mTOR pathway in chickens

被引:2
|
作者
Ruxia Wang [1 ,2 ]
Kelin Li [1 ]
Li Sun [1 ]
Hongchao Jiao [1 ]
Yunlei Zhou [1 ]
Haifang Li [1 ]
Xiaojuan Wang [1 ]
Jingpeng Zhao [1 ]
Hai Lin [1 ]
机构
[1] Key Lab for Animal Biotechnology and Disease Control, Department of Animal Science, Shandong Agricultural University
[2] Institute of Biological Resources, Jiangxi Academy of Sciences
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
S831.5 [饲料与营养];
学科分类号
090502 ;
摘要
L-Arginine(L-Arg), the precursor of nitric oxide(NO), plays an important role in muscle function. Fast-twitch glycolytic fibres are more susceptible to age-related atrophy than slow-twitch oxidative fibres.The effect of L-Arg/NO on protein metabolism of fast-and slow-twitch muscle fibres was evaluated in chickens. In Exp. 1, 48 chicks at 1 day old were divided into 4 groups of 12 birds and subjected to 4 treatments: basal diet without supplementation or supplemented with 1% L-Arg, and water supplemented with or without L-nitro-arginine methyl ester(L-NAME, 18.5 mM). In Exp. 2, 48 chicks were divided into 4 groups of 12 birds fed with the basal diet and subjected to the following treatments: tap water(control), tap water supplemented with L-NAME(18.5 m M), or molsidomine(MS, 0.1 mM), or 18.5 mM L-NAME + 0.1 mM MS(NAMS). The regulatory effect of L-Arg/NO was further investigated in vitro with myoblasts obtained from chicken embryo pectoralis major(PM) and biceps femoris(BF).In vivo, dietary L-Arg supplementation increased breast(+14.94%, P < 0.05) and thigh muscle mass(+23.40%, P < 0.05); whereas, MS treatment had no detectable influence. However, L-NAME treatment blocked the beneficial influence of L-Arg on muscle development. L-Arg decreased(P < 0.05) protein synthesis rate, phosphorylated mTOR and ribosomal protein S6 kinase beta-1(p70S6K) levels in breast muscle, which was recovered by L-NAME treatment. In vitro, L-Arg or sodium nitroprusside(SNP)reduced protein synthesis rate, suppressed phosphorylated m TOR/p70S6K and decreased atrogin-1 and muscle RING finger 1(MuRF1) in myoblasts from PM muscle(P < 0.05). L-NAME abolished the inhibitory effect of L-Arg on protein synthesis and the m TOR/p70S6K pathway. However, myoblasts from BF muscle showed the weak influence. Moreover, blocking the mTOR/p70S6K pathway with rapamycin suppressed protein synthesis of the 2 types of myoblasts; whereas, the protein expression of atrogin-1 and MuRF1 levels were restricted only in myoblasts from PM muscle. In conclusion, L-Arg/NO/mTOR/p70S6K pathway enhances protein accumulation and muscle development in fast-twitch glycolytic muscle in chickens. L-Arg/NO regulates protein turnover in a muscle fibre specific way, which highlights the potential clinical application in fast-twitch glycolytic muscle fibres.
引用
收藏
页码:68 / 85
页数:18
相关论文
共 50 条
  • [41] The L-arginine/nitric oxide pathway is impaired in overweight/obese pregnant women
    Petrella, Elisabetta
    Pignatti, Lucrezia
    Neri, Isabella
    Facchinetti, Fabio
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2014, 4 (02) : 150 - 155
  • [42] PRECONDITIONING OF THE ISCHEMIC MYOCARDIUM - INVOLVEMENT OF THE L-ARGININE NITRIC-OXIDE PATHWAY
    VEGH, A
    SZEKERES, L
    PARRATT, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) : 648 - 652
  • [43] Aspects of the L-arginine/nitric oxide pathway in normal pregnancy and preeclampsia syndrome
    da Costa, BP
    Ogando, P
    de Figueiredo, CP
    JOURNAL OF HYPERTENSION, 2004, 22 : S28 - S29
  • [44] THE L-ARGININE NITRIC-OXIDE PATHWAY IN THE RABBIT URETHRAL LAMINA PROPRIA
    ZYGMUNT, PKE
    PERSSON, K
    ALM, P
    LARSSON, B
    ANDERSSON, KE
    ACTA PHYSIOLOGICA SCANDINAVICA, 1993, 148 (04): : 431 - 439
  • [45] Analysis of the L-arginine/nitric oxide pathway: The unique role of mass spectrometry
    Tsikas, Dimitrios
    CURRENT PHARMACEUTICAL ANALYSIS, 2005, 1 (01) : 15 - 30
  • [46] Nitric Oxide and L-Arginine Deficiency in Cystic Fibrosis
    Grasemann, Hartmut
    Ratjen, Felix
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (05) : 726 - 736
  • [47] The role of L-arginine/nitric oxide pathway in the antinociceptive activity of pyridoxine in mouse
    Abacioglu, N
    Tunçtan, B
    Çakici, I
    Akbulut, E
    Uludag, O
    Kanzik, I
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2001, 51 (10): : 832 - 838
  • [48] L-ARGININE - NITRIC-OXIDE PATHWAY IN ENDOTOXEMIA AND HUMAN SEPTIC SHOCK
    GOMEZJIMENEZ, J
    SALGADO, A
    MOURELLE, M
    MARTIN, MC
    SEGURA, RM
    PERACAULA, R
    MONCADA, S
    CRITICAL CARE MEDICINE, 1995, 23 (02) : 253 - 258
  • [49] Effects of vitamin C on nitric oxide/L-arginine pathway in patients with atherosclerosis
    Tousoulis, D
    Davies, G
    Tentolouris, C
    Tousoulis, G
    Goumas, G
    Xenakis, C
    Pitsavos, C
    Brilli, S
    Antoniades, C
    Stefanadis, C
    Toutouzas, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 253A - 253A
  • [50] Modulation of the L-arginine/nitric oxide signalling pathway in vascular endothelial cells
    Wyatt, AW
    Steinert, JR
    Mann, GE
    FREE RADICALS: ENZYMOLOGY, SIGNALLING AND DISEASE, 2004, 71 : 143 - 156